Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
NeuBase Therapeutics enterprise value is not available.NBSE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
NBSE Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | -$3 M | -$6 M | ||
| 3 y | 3 years | $56 M | -$11 M | ||
| 5 y | 5 years | $260 M | -$11 M | ||
| alltime | all time | $389 M | -$11 M |
NeuBase Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2023 | -$4.44 M(-16.5%) |
| 2022 | -$5.32 M(-110.4%) |
| 2021 | $51.06 M(-61.9%) |
| 2020 | $134.04 M(+16.3%) |
| 2019 | $115.28 M(+6460.5%) |
| 2018 | $1.76 M(-98.2%) |
| 2017 | $96.25 M(+138.0%) |
| 2016 | $40.45 M(-75.4%) |
| Date | Value |
|---|---|
| 2015 | $164.77 M(-17.8%) |
| 2014 | $200.39 M(+30.7%) |
| 2013 | $153.27 M(+84.2%) |
| 2012 | $83.21 M(+223.5%) |
| 2011 | $25.73 M(+181.3%) |
| 2010 | $9.14 M(-44.6%) |
| 2009 | $16.51 M(-18.0%) |
| 2008 | $20.14 M(+14.1%) |
| 2007 | $17.64 M |
FAQ
- What is the all time high enterprise value for NeuBase Therapeutics?
What is the all time high enterprise value for NeuBase Therapeutics?
NeuBase Therapeutics all-time high enterprise value is $388.98 M